home / stock / ebs / ebs news


EBS News and Press, Emergent Biosolutions Inc. From 05/27/22

Stock Information

Company Name: Emergent Biosolutions Inc.
Stock Symbol: EBS
Market: NYSE
Website: emergentbiosolutions.com

Menu

EBS EBS Quote EBS Short EBS News EBS Articles EBS Message Board
Get EBS Alerts

News, Short Squeeze, Breakout and More Instantly...

EBS - Co-Diagnostics extends gains on monkeypox test development

The shares of Co-Diagnostics (NASDAQ:CODX) are trading higher for the third straight session on Friday in solidarity with makers of monkeypox vaccines and therapeutics after molecular diagnostics company announced its contribution to address the virus outbreak. Co-Diagnostics (CODX) said Thur...

EBS - 7 Monkeypox Stocks to Watch Right Now

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Emergent Biosolutions (NYSE: EBS ) – makes a proven smallpox vaccine that may be used for monkeypox Bavarian Nordic (OTCMKTS: BVNRY ) – boasts a monkeypox vaccine approved in the U.S. Inovio ...

EBS - Monkeypox cases rise prompting vaccinations in U.S., Britain, and Germany

Countries from the U.S. to Germany are planning to offer monkeypox vaccinations as the rare viral disease continues to spread outside Central and West Africa, where it is usually detected. On Tuesday, the World Health Organization (WHO) confirmed 131 monkeypox cases and another 106 suspected ...

EBS - Moderna enters monkeypox vaccine development

The COVID-19 vaccine maker Moderna (NASDAQ:MRNA) announces that the company is currently investigating potential monkeypox vaccines at a pre-clinical stage. The mRNA-based vaccine developer currently runs 46 programs in its pipeline, with 34 vaccines in the development. The Cambridge, Massach...

EBS - CDC outlines stocks of vaccines available for monkeypox treatment

The CDC said that it has over 1K doses of the Jynneos vaccine, made by Bavarian Nordic (OTCPK:BVNKF) (OTCPK:BVNRY), in the national stockpile and will release some of it soon, Reuters reported. Jynneos is the only U.S. FDA vaccine approved for monkeypox. In addition, the U.S. has more than 1M...

EBS - Hot Stocks: EBS rises on monkeypox fears; NTNX takeover speculation; NIU drops on earnings; SNOW price target cut

Takeover speculation and monkeypox concerns stirred trading in individual stocks during Monday's midday action. Nutanix (NTNX) received a boost from conjecture that it could become a takeover target for private equity. Meanwhile, smallpox vaccine maker Emergent Biosolutions (NYSE:EBS) garnere...

EBS - Why Emergent BioSolutions Stock Is Jumping Today

Shares of Emergent BioSolutions (NYSE: EBS) were jumping 12% as of 11:09 a.m. ET on Monday. The big gain was due to increased concerns about the spread of monkeypox. Emergent BioSolutions markets ACAM2000, a smallpox vaccine that could also help prevent monkeypox infection. The ...

EBS - Emergent BioSolutions opened 15% up on Monday: here's why

Emergent BioSolutions Inc ( NYSE: EBS ) opened another 15% up in the stock market this morning as global cases of Monkeypox continued to rise over the weekend. How does the outbreak affect Emergent BioSolutions? According to the Centres for Disease Control and Prevention, AC...

EBS - Stock Market Today: Dow Jones, S&P 500 Rise, VMware Stock In Focus On Potential Broadcom Acquisition

Stock Market Today Mid-Morning Updates On Monday, the Dow Jones Industrial Average is up by 240 points, after it posted its first eight-week losing streak in more than 80 years. The Nasdaq and S&P 500 have also posted their seven straight losing weeks. Notably, the S&P 5...

EBS - SIGA, Emergent extend gains as monkeypox cases rise

As monkeypox cases continue to rise worldwide, a group of companies focused on therapeutics and vaccines targeted at a close relative of the virus has extended their recent gains in the pre-market on Monday. Monkeypox is a rare viral disease most common in remote parts of Central and West Afr...

Previous 10 Next 10